Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MTBVAC for efficacy, safety, and immunogenicity in adolescents and adults in a tuberculosis-endemic region; recruitment is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MTBVAC

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: Tuberculosis (TB) | Phase 2 | Status: RECRUITING